Vnitr Lek 1985, 31(8):806-809
[At the present level of anticoagulation therapy with Pelentan, is it possible to expect effective prevention of thromboembolism?].
Klíčová slova: Ethyl Biscoumacetate, therapeutic use, ; Female; Humans; Male; Thromboembolism, prevention & control,
Keywords: Ethyl Biscoumacetate /therapeutic use/; Female; Humans; Male; Thromboembolism /prevention & control/
Zveřejněno: 1. srpen 1985 Zobrazit citaci